20n Bio is a VC-backed start-up dedicated to designing and screening cyclic peptides for therapeutics. Launched in 2021 and located in Malvern PA, its mission is addressing unmet medical needs by leveraging high-throughput screening and computing to generate peptide drugs with desired biophysical, functional, and pharmacological properties.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Great Philadelphia, Pa, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://20n.bio
- HQ
- Great Philadelphia, PA
20n Bio Questions
20N Bio's website is http://20n.bio
20N Bio's LinkedIn profile is https://www.linkedin.com/company/20nbio
20N Bio has
5 employees.
View email and phone details for 5
employees at 20N Bio.
20N Bio's industry is
Biotechnology Research
20N Bio's top competitors are
Biopeptek Pharmaceuticals Llc,
Abzyme Therapeutics,
Chimeron Bio,
Aclipse Therapeutics,
Ocms Bio,
Panorama Medicine,
Hula Therapeutics,
Cytoex Inc.,
Silence Therapeutics Plc,
Longevity Biotech.
20N Bio's categories are Biotechnology Research
20N Bio's founding year is 2021
